Mutations

MAPT IVS10+29 G>A

Tools

Back to the Top

Overview

Pathogenicity: Alzheimer's Disease : Not Classified
Clinical Phenotype Studied: Alzheimer's Disease
Position: (GRCh38/hg38):Chr17:46010431 G>A
Position: (GRCh37/hg19):Chr17:44087797 G>A
dbSNP ID: rs63751443
Coding/Non-Coding: Non-Coding
DNA Change: Substitution
Expected RNA Consequence: Substitution
Codon Change: G to A
Genomic Region: Intron 10

Findings

This intronic polymorphism was initially identified in one of 117 controls and zero of 101 people affected by early onset Alzheimer's disease (Roks et al., 1999). It was later found in two of 72 AD patients and zero of 58 controls (Sala Frigerio et al., 2015). In the gnomAD variant database, it is reported at a global frequency of 0.0034, with the highest frequencies in Ashkenazi Jews and non-Finnish Europeans (v4.1.0, Apr 2024). This variant does not appear to alter the splicing of exon 10 (D'Souza et al., 1999), and its PHRED-scaled CADD score (1.24), which integrates diverse information in silico, was well below the commonly used threshold of 20 to predict deleteriousness (CADD v1.7, Apr 2024).

Last Updated: 28 Oct 2025

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

References

Paper Citations

  1. . Mutation screening of the tau gene in patients with early-onset Alzheimer's disease. Neurosci Lett. 1999 Dec 24;277(2):137-9. PubMed.
  2. . On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients. Alzheimers Dement. 2015 Nov;11(11):1265-76. Epub 2015 Apr 29 PubMed.
  3. . Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5598-603. PubMed.

Further Reading

No Available Further Reading

Protein Diagram

Primary Papers

  1. . Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5598-603. PubMed.
  2. . Mutation screening of the tau gene in patients with early-onset Alzheimer's disease. Neurosci Lett. 1999 Dec 24;277(2):137-9. PubMed.

Alzpedia

Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.